Literature DB >> 33128093

Challenges for Women Entering Treatment for Opioid Use Disorder.

Andrew S Huhn1, Kelly E Dunn2.   

Abstract

PURPOSE OF REVIEW: Women with opioid use disorder (OUD) face unique challenges the moment they enter treatment. This narrative review focused on recent literature regarding sex- and gender-based issues that could affect treatment outcomes in women with OUD. RECENT
FINDINGS: Women respond differently to opioids based on hormonal factors, are more likely to present to treatment with mental health conditions, especially depression, and are more likely to have experienced trauma via intimate partner violence compared with men. Women also face stigma when entering OUD treatment, particularly if they have children. Future research to improve OUD treatment outcomes in women should account for sex as a biological variable and gender as a social construct. Women have a fundamentally different experience than men during the course of OUD and upon treatment entry. Programs that address childcare/family support, mental health, and trauma are warranted for women with OUD.

Entities:  

Keywords:  Gender differences; Mental health; Opioid use disorder; Sex differences; Trauma; Women

Year:  2020        PMID: 33128093     DOI: 10.1007/s11920-020-01201-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  7 in total

1.  Gender differences among persons entering medication treatment for opioid use disorder in the community.

Authors:  Angela Di Paola; Noor Taweh; Breanne E Biondi; Ariadna Forray; Cynthia A Frank; Albert Shaw; Sandra A Springer
Journal:  Am J Addict       Date:  2022-06-02

2.  Modulation of heroin intake by ovarian hormones in gonadectomized and intact female rats.

Authors:  Mark A Smith; Sarah B Ethridge; Tallia Pearson; Huailin Zhang; Madison M Marcus; Shannon L Ballard; Alexander T Casimir; Kenzie M Potter; Karl T Schmidt; Jessica L Sharp; Andrea M Robinson
Journal:  Psychopharmacology (Berl)       Date:  2021-01-06       Impact factor: 4.530

3.  Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use.

Authors:  Jennifer D Ellis; Jill A Rabinowitz; Jonathan Wells; Fangyu Liu; Patrick H Finan; Michael D Stein; Denis G Antoine Ii; Gregory J Hobelmann; Andrew S Huhn
Journal:  J Affect Disord       Date:  2021-12-04       Impact factor: 4.839

4.  Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration.

Authors:  Eleanor Blair Towers; Ben Setaro; Wendy J Lynch
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.988

5.  Positive associations between cannabis and alcohol use polygenic risk scores and phenotypic opioid misuse among African-Americans.

Authors:  Jill A Rabinowitz; Jin Jin; Sally I-Chun Kuo; Adrian I Campos; Miguel E Rentería; Andrew S Huhn; Johannes Thrul; Beth A Reboussin; Kelly Benke; Benjamin Domingue; Nicholas S Ialongo; Brion S Maher; Darlene Kertes; Vanessa Troiani; George Uhl
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

6.  Under-representation of key demographic groups in opioid use disorder trials.

Authors:  Kara E Rudolph; Matthew Russell; Sean X Luo; John Rotrosen; Edward V Nunes
Journal:  Drug Alcohol Depend Rep       Date:  2022-07-30

7.  Adults With Opioid and Methamphetamine Co-use Have Lower Odds of Completing Short-Term Residential Treatment Than Other Opioid Co-use Groups: A Retrospective Health Services Study.

Authors:  Orrin D Ware; Jennifer I Manuel; Andrew S Huhn
Journal:  Front Psychiatry       Date:  2021-12-08       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.